指南与共识胰腺与胆道疾病消化内镜

2019与2010 ASGE指南预测胆总管结石诊断准确性比较

Comparing diagnostic accuracy of current practice guidelines in predicting choledocholithiasis: outcomes from a large healthcare system comprising both academic and community settings.
指南 / 共识 · Gastrointest Endosc · 2020-11-05

该回顾性研究纳入744例因疑似胆总管结石行ERCP的患者,比较2019与2010 ASGE指南的风险分层性能。2019指南高危组比例更低(36.8% vs 60.4%),高危组确诊结石率更高(82.5% vs 76.2%),总体特异性从46.5%提升至76.0%,但阳性预测值和阴性预测值无显著变化。

要点

  • 2019 ASGE指南较2010版显著提高特异性(76.0% vs 46.5%),减少不必要ERCP。
  • 2019指南高危组比例更低,但高危组中确诊结石比例更高。
  • 2019指南下大量患者归为中危,需额外影像学确认。

核心结论

  • 2019 ASGE指南较2010指南在ERCP中检测胆总管结石更具特异性。
  • 2019指南将大量患者归为中危,需额外确认性影像学检查。

研究设计与样本

  • 回顾性病历审查,基于2013-2019年前瞻性维护数据库,涵盖14家医院70位消化科医生完成的超过10000例ERCP。
  • 随机选取744例以疑似胆总管结石为主要指征的ERCP,排除有胆囊切除史或既往括约肌切开史的患者。
  • 同一队列按2010和2019 ASGE指南标准分为低、中、高危,以ERCP发现结石和/或胆泥为参照比较总体准确性。

主要发现

  • 744例ERCP中,544例(73.1%)ERCP证实明确结石,696例(93.5%)ERCP证实结石和/或胆泥。
  • 2019指南高危组274/744(36.8%),低于2010指南的449/744(60.4%),P < .001。
  • 高危组中ERCP确诊结石率2019指南为226/274(82.5%),高于2010指南的342/449(76.2%),P < .001。
  • 2010指南总体特异性46.5%,2019指南提升至76.0%,P < .001。
  • 2019与2010指南的阳性预测值和阴性预测值无显著变化。

关键数值与推荐

  • 2019 ASGE指南高危组比例36.8%(274/744),2010指南为60.4%(449/744),P < .001。
  • 2019指南高危组确诊结石率82.5%(226/274),2010指南为76.2%(342/449),P < .001。
  • 2019指南总体特异性76.0%,2010指南为46.5%,P < .001。

临床怎么用

  • 应用2019 ASGE指南可提高高危患者选择特异性,减少不必要的直接ERCP。
  • 对2019指南归为中危的患者,需安排额外确认性影像学检查后再决定ERCP。

局限性

  • 回顾性研究设计。
  • 单医疗系统数据,虽涵盖学术与社区环境。
  • 排除胆囊切除史或既往括约肌切开史患者,可能限制外推性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The American Society for Gastrointestinal Endoscopy (ASGE) 2010 guidelines for suspected choledocholithiasis were recently updated by proposing more specific criteria for selection of high-risk patients to undergo direct ERCP while advocating the use of additional imaging studies for intermediate- and low-risk individuals. We aim to compare the performance and diagnostic accuracy of 2019 versus 2010 ASGE criteria for suspected choledocholithiasis. METHODS: We performed a retrospective chart review of a prospectively maintained database (2013-2019) of over 10,000 ERCPs performed by 70 gastroenterologists in our 14-hospital system. We randomly selected 744 ERCPs in which the primary indication was suspected choledocholithiasis. Patients with a history of cholecystectomy or prior sphincterotomy were excluded. The same patient cohort was assigned as low, intermediate, or high risk according to the 2010 and 2019 guideline criteria. Overall accuracy of both guidelines was compared against the presence of stones and/or sludge on ERCP. RESULTS: Of 744 patients who underwent ERCP, 544 patients (73.1%) had definite stones during ERCP and 696 patients (93.5%) had stones and/or sludge during ERCP. When classified according to the 2019 guidelines, fewer patients were high risk (274/744, 36.8%) compared with 2010 guidelines (449/744, 60.4%; P < .001). Within the high-risk group per both guidelines, definitive stone was found during ERCP more frequently in the 2019 guideline cohort (226/274, 82.5%) compared with the 2010 guideline cohort (342/449, 76.2%; P < .001). In our patient cohort, overall specificity of the 2010 guideline was 46.5%, which improved to 76.0% as per 2019 guideline criteria (P < .001). However, no significant change was noted for either positive predictive value or negative predictive value between 2019 and 2010 guidelines. CONCLUSIONS: The 2019 ASGE guidelines are more specific for detection of choledocholithiasis during ERCP when compared with the 2010 guidelines. However, a large number of patients are categorized as intermediate risk per 2019 guidelines and will require an additional confirmatory imaging study.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Chandran A, Rashtak S, Patil P, et al. Comparing diagnostic accuracy of current practice guidelines in predicting choledocholithiasis: outcomes from a large healthcare system comprising both academic and community settings. Gastrointest Endosc. 2020. PMID: 33160977. doi:10.1016/j.gie.2020.10.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。